New Weight Loss Drug CagriSema Shows Impressive Results in Clinical Trials Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide and Retatrutide for Men: Uses, Evidence, and UK Access Bolt Pharmacy CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes New England Journal of Medicine